AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo

被引：19
|
作者：
Yu, M. [1 ,2 ]
Gang, E. J. [3 ,4 ]
Parameswaran, R. [1 ,2 ]
Stoddart, S. [1 ,2 ]
Fei, F. [1 ,2 ]
Schmidhuber, S. [1 ,2 ]
Park, E. [3 ,4 ]
Hsieh, Y. T. [3 ,4 ]
Yang, A. S. [5 ]
Groffen, J. [1 ,2 ,3 ,4 ]
Heisterkamp, N. [1 ,2 ,3 ,4 ]
Kim, Y. M. [3 ,4 ]
机构：
[1] Childrens Hosp Los Angeles, Sect Mol Carcinogenesis, Div Hematol Oncol, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA
[3] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA
[4] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
[5] Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Ctr Blood Dis,Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA
来源：
BLOOD CANCER JOURNAL | 2011年 / 1卷
关键词：
CXCR4; ANTAGONIST; MICROENVIRONMENT; MOBILIZATION; RESISTANCE; INHIBITORS; AML;
D O I：
10.1038/bcj.2011.13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e14 / e14
页数：3
相关论文
共 50 条
  • [41] Mobilization of bone marrow stem/progenitor cells by AMD3100 or G-CSF is impaired in diabetes
    Vasam, Goutham
    Bartelmez, Stephen
    Jarajapu, Yagna
    FASEB JOURNAL, 2014, 28 (01):
  • [42] A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100
    Lack, NA
    Green, B
    Dale, DC
    Calandra, GB
    Lee, H
    MacFarland, RT
    Badel, K
    Liles, WC
    Bridger, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (05) : 427 - 436
  • [43] The Combination of GROβ and AMD3100 Leads to Rapid and Robust Mobilization of Hematopoietic Stem Cells in Nonhuman Primates
    Falahee, Patrick C.
    Goncalves, Kevin A.
    Hyzy, Sharon L.
    Proctor, Jennifer L.
    Hoggatt, Jonathan
    Morrow, Dwight
    Cooke, Michael P.
    BLOOD, 2017, 130
  • [44] AMD3100 and G-CSF for poor mobilisers; successful harvest of stem cells in a child with cancer
    Bateman, CM
    Stephen, K
    Calandra, G
    Shaw, PJ
    BONE MARROW TRANSPLANTATION, 2005, 35 : S105 - S105
  • [45] The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
    Tavor, S.
    Eisenbach, M.
    Jacob-Hirsch, J.
    Golan, T.
    Petit, I.
    BenZion, K.
    Kay, S.
    Baron, S.
    Amariglio, N.
    Deutsch, V.
    Naparstek, E.
    Rechavi, G.
    LEUKEMIA, 2008, 22 (12) : 2151 - 2158
  • [46] AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates
    Larochelle, A
    Krouse, A
    Metzger, M
    Orlic, D
    Donahue, RE
    Fricker, S
    Bridger, G
    Dunbar, CE
    Hematti, P
    BLOOD, 2006, 107 (09) : 3772 - 3778
  • [47] Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100
    Shepherd, Rebecca M.
    Capoccia, Benjamin J.
    Devine, Steven M.
    DiPersio, John
    Trinkaus, Kathryn M.
    Ingram, David
    Link, Daniel C.
    BLOOD, 2006, 108 (12) : 3662 - 3667
  • [48] Blockage of SDF-1-CXCR4 Axis by AMD 3100 Can Be a Novel Therapy for Acute Lymphoblastic Leukemia by Targeting the Extramedullary Sites of Leukemic Cells
    Kato, Itaru
    Niwa, Akira
    Fujino, Hisanori
    Umeda, Katsutsugu
    Saida, Satoshi
    Adachi, Souichi
    Ito, Mamoru
    Heike, Toshio
    Nakahata, Tatsutoshi
    BLOOD, 2009, 114 (22) : 407 - 408
  • [49] The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
    S Tavor
    M Eisenbach
    J Jacob-Hirsch
    T Golan
    I Petit
    K BenZion
    S Kay
    S Baron
    N Amariglio
    V Deutsch
    E Naparstek
    G Rechavi
    Leukemia, 2008, 22 : 2151 - 2158
  • [50] AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse
    Samuelson, Clare
    Radtke, Stefan
    Cui, Margaret
    Perez, Anai
    Kiem, Hans-Peter
    Humbert, Olivier
    EXPERIMENTAL HEMATOLOGY, 2021, 93 : 52 - U21
12345